Holen Sie sich die Stockscreener-App
90.16
0.18%
0.16
Handel nachbörslich:
90.16
Schlusskurs vom Vortag:
$90.00
Offen:
$90
24-Stunden-Volumen:
409.82K
Relative Volume:
0.96
Marktkapitalisierung:
$2.95B
Einnahmen:
$2.29B
Nettoeinkommen (Verlust:
$91.98M
KGV:
1,288.00
EPS:
0.07
Netto-Cashflow:
$88.47M
1W Leistung:
-0.14%
1M Leistung:
-7.43%
6M Leistung:
-6.29%
1J Leistung:
-3.78%
1-Tages-Spanne:
$89.78
$90.21
1-Wochen-Bereich:
$88.81
$90.47
52-Wochen-Spanne:
$88.81
$98.95
Amedisys Inc Stock (AMED) Company Profile
Firmenname
Amedisys Inc
Sektor
Branche
Telefon
(225) 292-2031
Adresse
3854 AMERICAN WAY, BATON ROUGE, LA
Vergleichen Sie AMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| AMED | 90.16 | 2.95B | 2.29B | 91.98M | 88.47M | 0.07 |
| HCA | 332.24 | 82.59B | 69.62B | 5.93B | 5.88B | 20.33 |
| THC | 147.92 | 14.45B | 20.97B | 3.13B | 2.39B | 4.33 |
| DVA | 164.14 | 13.46B | 12.67B | 827.68M | 1.42B | 5.03 |
| FMS | 21.98 | 12.90B | 20.87B | 715.19M | 2.10B | 0.8156 |
| UHS | 197.61 | 12.89B | 15.42B | 1.03B | 956.84M | 9.53 |
Amedisys Inc Stock (AMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-06-07 | Herabstufung | Truist | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-03-13 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-27 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-08-02 | Herabstufung | UBS | Neutral → Sell |
| 2022-06-29 | Eingeleitet | Stifel | Hold |
| 2022-06-21 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-01 | Hochstufung | UBS | Sell → Neutral |
| 2022-02-25 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-02-25 | Bestätigt | Credit Suisse | Outperform |
| 2022-02-25 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-25 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-02-25 | Bestätigt | Raymond James | Outperform |
| 2022-02-25 | Bestätigt | Truist | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-24 | Eingeleitet | UBS | Sell |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-10 | Bestätigt | The Benchmark Company | Buy |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-08-20 | Fortgesetzt | Barclays | Overweight |
| 2020-07-30 | Bestätigt | The Benchmark Company | Buy |
| 2020-06-18 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-05-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-03-09 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-01-17 | Eingeleitet | Credit Suisse | Outperform |
| 2019-11-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-10-22 | Fortgesetzt | Stephens | Equal-Weight |
| 2019-09-17 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-12-14 | Eingeleitet | Barclays | Equal Weight |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-10-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2018-07-03 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-03-19 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-11-09 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-11-08 | Bestätigt | Mizuho | Buy |
| 2017-11-02 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-08-21 | Eingeleitet | BofA/Merrill | Neutral |
Alle ansehen
Amedisys Inc Aktie (AMED) Neueste Nachrichten
Why the DOJ’s Lawsuit Against the UGH-Amedisys Merger May Not Go Anywhere - MedCity News
US Justice Department preps suit over UnitedHealth-Amedisys deal, Bloomberg News reports - MSN
US sues to block UnitedHealth's $3.3 billion purchase of Amedisys - MSN
Justice Department sues to block UnitedHealth Group's $3.3 billion purchase of Amedisys - MSN
Alpine Associates Management Inc. Decreases Stock Position in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
DOJ sues UnitedHealth amid $3.3 billion bid to buy home care giant Amedisys - MSN
Principal Financial Group Inc. Sells 33,149 Shares of Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
U.S. Justice Department moves to block big healthcare purchase - Nevada Current
DOJ Challenges UnitedHealth And Amedisys Merger - Evrim Ağacı
ACA subsidy optimism and a fiery antitrust speech - STAT
Amedisys stock touches 52-week low at $89.54 amid market shifts - Investing.com
Inside the Justice Department’s Amedisys-Optum Lawsuit - Hospice News
LMR Partners LLP Reduces Stake in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Amedisys Earnings: An Early Look - AOL
ING Groep NV Cuts Stock Position in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal - MSN
Justice Department and four Attorneys General block $3.3 billion acquisition of Amedisys Inc. - MSN
DOJ is suing to block UnitedHealth's $3.3 billion purchase of Amedisys - Fortune
UnitedHealth's Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape - AOL
Evaluating The DOJ’s Arguments Against The UnitedHealth Group-Amedisys Deal - Home Health Care News
Justice Department sues to block UnitedHealth Group’s $3.3 billion purchase of Amedisys - Nashua Telegraph
DOJ Sues to Stop UnitedHealth's Amedisys Acquisition - Newser
Juniper Networks falls as DOJ sues to block Amedisys sale to UnitedHealth - MSN
DOJ files lawsuit to block UnitedHealth from purchasing Amedisys - The San Joaquin Valley Sun
DOJ sues to block UnitedHealth Group’s acquisition of Amedisys - BenefitsPro
DOJ sues to block UnitedHealth’s acquisition of Amedisys - Business Insurance
DOJ sues to block UnitedHealth's acquisition of Amedisys - Healthcare Finance News
$3B Health Care Merger Would Be Bad For New Jersey, Other States: Feds - Patch
New York Attorney General Letitia James joins lawsuit against UnitedHealth Group merger - CNYcentral.com
DOJ prepares lawsuit to block UnitedHealth Group’s acquisition of Amedisys - BenefitsPro
Justice Department sues to block United Health merger with Amedisys - ConsumerAffairs
UnitedHealth-Amedisys merger targeted by Justice Department - The Business Journals
DOJ sues UnitedHealth/Amedisys to shut down “massive healthcare ecosystem” - Global Competition Review
New York attorney general joins lawsuit to block UnitedHealth, Amedisys merger - MSN
Why UnitedHealth, Amedisys are standing behind their deal - Modern Healthcare
Justice Department Blocks UnitedHealth's Amedisys Acquisition - Evrim Ağacı
Finanzdaten der Amedisys Inc-Aktie (AMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):